Titre : Stérigmatocystine

Stérigmatocystine : Questions médicales fréquentes

Termes MeSH sélectionnés :

Gene Expression Profiling
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Stérigmatocystine : Questions médicales les plus fréquentes", "headline": "Stérigmatocystine : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Stérigmatocystine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-02", "dateModified": "2025-02-25", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Stérigmatocystine" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Mycotoxines", "url": "https://questionsmedicales.fr/mesh/D009183", "about": { "@type": "MedicalCondition", "name": "Mycotoxines", "code": { "@type": "MedicalCode", "code": "D009183", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.587" } } }, "about": { "@type": "MedicalCondition", "name": "Stérigmatocystine", "alternateName": "Sterigmatocystin", "code": { "@type": "MedicalCode", "code": "D013241", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Veronica Zingales", "url": "https://questionsmedicales.fr/author/Veronica%20Zingales", "affiliation": { "@type": "Organization", "name": "Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Av. Vicent Andrés Estellés s/n, 46100, Valencia, Spain. Electronic address: vezin@uv.es." } }, { "@type": "Person", "name": "Mónica Fernández-Franzón", "url": "https://questionsmedicales.fr/author/M%C3%B3nica%20Fern%C3%A1ndez-Franz%C3%B3n", "affiliation": { "@type": "Organization", "name": "Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Av. Vicent Andrés Estellés s/n, 46100, Valencia, Spain." } }, { "@type": "Person", "name": "Maria-José Ruiz", "url": "https://questionsmedicales.fr/author/Maria-Jos%C3%A9%20Ruiz", "affiliation": { "@type": "Organization", "name": "Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Av. Vicent Andrés Estellés s/n, 46100, Valencia, Spain." } }, { "@type": "Person", "name": "Ildikó Bata-Vidács", "url": "https://questionsmedicales.fr/author/Ildik%C3%B3%20Bata-Vid%C3%A1cs", "affiliation": { "@type": "Organization", "name": "Department of Environmental and Applied Microbiology, Agro-Environmental Research Institute, National Agricultural Research and Innovation Centre, 1022 Budapest, Hungary." } }, { "@type": "Person", "name": "József Kukolya", "url": "https://questionsmedicales.fr/author/J%C3%B3zsef%20Kukolya", "affiliation": { "@type": "Organization", "name": "Department of Environmental and Applied Microbiology, Agro-Environmental Research Institute, National Agricultural Research and Innovation Centre, 1022 Budapest, Hungary." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Genome-wide identification and expression profiling of sugar transporter genes in tobacco.", "datePublished": "2022-06-14", "url": "https://questionsmedicales.fr/article/35714802", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.gene.2022.146652" } }, { "@type": "ScholarlyArticle", "name": "Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy.", "datePublished": "2023-08-02", "url": "https://questionsmedicales.fr/article/37533202", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cam4.6411" } }, { "@type": "ScholarlyArticle", "name": "The NeuroinflammatoryPotential of HIV-1 NefVariants in Modulating the Gene Expression Profile of Astrocytes.", "datePublished": "2022-10-17", "url": "https://questionsmedicales.fr/article/36291123", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/cells11203256" } }, { "@type": "ScholarlyArticle", "name": "Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression.", "datePublished": "2022-06-30", "url": "https://questionsmedicales.fr/article/35771282", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00401-022-02460-1" } }, { "@type": "ScholarlyArticle", "name": "Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies.", "datePublished": "2024-09-24", "url": "https://questionsmedicales.fr/article/39317454", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/rmdopen-2024-004600" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Facteurs biologiques", "item": "https://questionsmedicales.fr/mesh/D001685" }, { "@type": "ListItem", "position": 3, "name": "Toxines biologiques", "item": "https://questionsmedicales.fr/mesh/D014118" }, { "@type": "ListItem", "position": 4, "name": "Mycotoxines", "item": "https://questionsmedicales.fr/mesh/D009183" }, { "@type": "ListItem", "position": 5, "name": "Stérigmatocystine", "item": "https://questionsmedicales.fr/mesh/D013241" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Stérigmatocystine - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Stérigmatocystine", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Stérigmatocystine", "description": "Comment diagnostiquer une intoxication à la stérigmatocystine ?\nQuels tests sont utilisés pour détecter la stérigmatocystine ?\nQuels symptômes indiquent une exposition à la stérigmatocystine ?\nY a-t-il des marqueurs biologiques spécifiques ?\nComment évaluer l'exposition environnementale ?", "url": "https://questionsmedicales.fr/mesh/D013241?mesh_terms=Gene+Expression+Profiling&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Stérigmatocystine", "description": "Quels sont les symptômes d'une intoxication aiguë ?\nLa stérigmatocystine cause-t-elle des effets à long terme ?\nQuels signes indiquent une atteinte hépatique ?\nY a-t-il des symptômes neurologiques associés ?\nComment les symptômes varient-ils selon l'exposition ?", "url": "https://questionsmedicales.fr/mesh/D013241?mesh_terms=Gene+Expression+Profiling&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Stérigmatocystine", "description": "Comment prévenir l'exposition à la stérigmatocystine ?\nQuelles mesures de sécurité en milieu de travail ?\nLes tests de qualité des aliments sont-ils utiles ?\nComment gérer les cultures à risque ?\nY a-t-il des recommandations pour les consommateurs ?", "url": "https://questionsmedicales.fr/mesh/D013241?mesh_terms=Gene+Expression+Profiling&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Stérigmatocystine", "description": "Quel est le traitement principal pour l'intoxication ?\nDes antidotes existent-ils pour la stérigmatocystine ?\nComment gérer les symptômes gastro-intestinaux ?\nQuand faut-il hospitaliser un patient ?\nY a-t-il des traitements préventifs ?", "url": "https://questionsmedicales.fr/mesh/D013241?mesh_terms=Gene+Expression+Profiling&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Stérigmatocystine", "description": "Quelles sont les complications possibles d'une intoxication ?\nComment la stérigmatocystine affecte-t-elle le foie ?\nY a-t-il un risque de cancer associé ?\nQuels sont les effets sur le système immunitaire ?\nDes effets sur la reproduction sont-ils possibles ?", "url": "https://questionsmedicales.fr/mesh/D013241?mesh_terms=Gene+Expression+Profiling&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Stérigmatocystine", "description": "Qui est le plus à risque d'intoxication ?\nLes enfants sont-ils plus vulnérables ?\nQuel rôle joue l'alimentation dans le risque ?\nLes personnes immunodéprimées sont-elles à risque ?\nComment l'environnement influence-t-il le risque ?", "url": "https://questionsmedicales.fr/mesh/D013241?mesh_terms=Gene+Expression+Profiling&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication à la stérigmatocystine ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques pour détecter la toxine." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter la stérigmatocystine ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter la présence de la toxine." } }, { "@type": "Question", "name": "Quels symptômes indiquent une exposition à la stérigmatocystine ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, vomissements, et des troubles hépatiques." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs biologiques spécifiques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de marqueurs spécifiques, mais des tests hépatiques peuvent montrer des anomalies." } }, { "@type": "Question", "name": "Comment évaluer l'exposition environnementale ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des échantillons d'air et de sol peuvent être analysés pour détecter la présence de champignons producteurs." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une intoxication aiguë ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes aigus incluent des douleurs abdominales, des vomissements et des diarrhées." } }, { "@type": "Question", "name": "La stérigmatocystine cause-t-elle des effets à long terme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une exposition prolongée peut entraîner des effets cancérigènes et des dommages hépatiques." } }, { "@type": "Question", "name": "Quels signes indiquent une atteinte hépatique ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent une jaunisse, des douleurs dans l'hypocondre droit et des anomalies des tests hépatiques." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes neurologiques comme des maux de tête et des vertiges peuvent survenir." } }, { "@type": "Question", "name": "Comment les symptômes varient-ils selon l'exposition ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes varient selon la dose et la durée d'exposition, allant de légers à graves." } }, { "@type": "Question", "name": "Comment prévenir l'exposition à la stérigmatocystine ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez de consommer des aliments moisis et assurez-vous d'une bonne conservation des aliments." } }, { "@type": "Question", "name": "Quelles mesures de sécurité en milieu de travail ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des mesures de sécurité incluent l'utilisation d'équipements de protection et une bonne ventilation." } }, { "@type": "Question", "name": "Les tests de qualité des aliments sont-ils utiles ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests réguliers peuvent aider à détecter la présence de mycotoxines dans les aliments." } }, { "@type": "Question", "name": "Comment gérer les cultures à risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Il est essentiel de surveiller et de contrôler l'humidité et la température des cultures." } }, { "@type": "Question", "name": "Y a-t-il des recommandations pour les consommateurs ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les consommateurs doivent inspecter les aliments et éviter ceux présentant des signes de moisissure." } }, { "@type": "Question", "name": "Quel est le traitement principal pour l'intoxication ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement consiste principalement en des soins de soutien et l'élimination de la toxine." } }, { "@type": "Question", "name": "Des antidotes existent-ils pour la stérigmatocystine ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique pour la stérigmatocystine." } }, { "@type": "Question", "name": "Comment gérer les symptômes gastro-intestinaux ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des antiémétiques et des réhydratations peuvent être administrés pour soulager les symptômes." } }, { "@type": "Question", "name": "Quand faut-il hospitaliser un patient ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "L'hospitalisation est nécessaire en cas de symptômes graves ou de défaillance hépatique." } }, { "@type": "Question", "name": "Y a-t-il des traitements préventifs ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La prévention repose sur l'évitement de l'exposition aux champignons producteurs de toxines." } }, { "@type": "Question", "name": "Quelles sont les complications possibles d'une intoxication ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des lésions hépatiques, des troubles neurologiques et un risque accru de cancer." } }, { "@type": "Question", "name": "Comment la stérigmatocystine affecte-t-elle le foie ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut provoquer une hépatite toxique, entraînant des dommages cellulaires et une insuffisance hépatique." } }, { "@type": "Question", "name": "Y a-t-il un risque de cancer associé ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition prolongée à la stérigmatocystine est associée à un risque accru de cancer du foie." } }, { "@type": "Question", "name": "Quels sont les effets sur le système immunitaire ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La stérigmatocystine peut affaiblir le système immunitaire, augmentant la susceptibilité aux infections." } }, { "@type": "Question", "name": "Des effets sur la reproduction sont-ils possibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent que la stérigmatocystine peut avoir des effets néfastes sur la reproduction." } }, { "@type": "Question", "name": "Qui est le plus à risque d'intoxication ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes travaillant dans l'agriculture ou la transformation des aliments sont plus à risque." } }, { "@type": "Question", "name": "Les enfants sont-ils plus vulnérables ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants sont plus vulnérables aux effets toxiques en raison de leur poids corporel plus faible." } }, { "@type": "Question", "name": "Quel rôle joue l'alimentation dans le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en aliments moisis augmente le risque d'exposition à la stérigmatocystine." } }, { "@type": "Question", "name": "Les personnes immunodéprimées sont-elles à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes immunodéprimées sont plus susceptibles de subir des effets graves de la toxine." } }, { "@type": "Question", "name": "Comment l'environnement influence-t-il le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Des conditions humides et chaudes favorisent la croissance des champignons producteurs de toxines." } } ] } ] }

Sources (10000 au total)

Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy.

Pancreatic ductal adenocarcinoma (PDAC) has the lowest survival rate of all major cancers. Chemotherapy is the mainstay systemic therapy for PDAC, and chemoresistance is a major clinical problem leadi... Archived formalin-fixed paraffin-embedded tumor tissue samples from patients treated with neoadjuvant chemotherapy were obtained during surgical resection. Specimens were macrodissected and gene expre... Initially, unsupervised multivariate modeling was performed by principal component analysis, which demonstrated a distinct gene expression profile between good- and poor-chemotherapy responders. There... A distinct tumor biological profile between PDAC patients who either respond or not respond to chemotherapy was identified....

Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies.

To identify differentially expressed genes in temporal artery biopsies (TABs) from patients with giant cell arteritis (GCA) with different histological patterns of inflammation: transmural inflammatio... Expression of 770 immune-related genes was profiled with the NanoString nCounter PanCancer Immune Profiling Panel on formalin-fixed paraffin-embedded TABs from 42 GCA patients with TMI, 7 GCA patients... Unsupervised clustering of the samples revealed two distinct groups: normal TABs and TABs with ILA in one group, 41/42 TABs with TMI in the other one. TABs with TMI showed 31 downregulated and 256 upr... TABs with TMI had a distinct transcriptome compared with normal TABs and TABs with ILA. The few genes potentially deregulated in ILA were also deregulated in TMI. Gene profiling allowed to deepen the ...

Identification and Validation of Common Reference Genes for Normalization of Esophageal Squamous Cell Carcinoma Gene Expression Profiles.

Esophageal squamous cell carcinoma (ESCC) is one of the subtypes of esophageal cancer with Chinese characteristics, and its five-year survival rate is less than 20%. Early diagnosis is beneficial to i...

Identification and Validation of Autophagy-Related Genes in Primary Ovarian Insufficiency by Gene Expression Profile and Bioinformatic Analysis.

To investigate the relationship between primary ovarian insufficiency and autophagy, we detected and got the expression profile of human granulosa cell line SVOG, which was with or without LPS induced... Totally, 6 genes were selected as candidate hub genes which might correlate with the process of primary ovarian insufficiency. The expression of hub genes was then validated by quantitative real-time ... The results indicated that autophagy might play an essential role in the process and underlying molecular mechanism of primary ovarian insufficiency, which was revealed for the first time and may help...

Intralesional gene expression profile of JAK-STAT signaling pathway and associated cytokines in

The JAK-STAT signaling pathway is a central cascade of signal transduction for the myriad of cytokines in which dysregulation has been implicated in progression of inflammatory and infectious diseases... This study sought to investigate differential gene expression of several cytokines and their associated... Results showed that the gene expression levelsof both Th1 (... Our finding revealed dysregulation of cytokines and related...

Identification and gene expression profiling of human gonadotrophic pituitary adenoma stem cells.

Gonadotrophic pituitary adenoma is a major subtype of pituitary adenoma in the sellar region, but it is rarely involved in the hypersecretion of hormones into blood; thus, it is commonly regarded as "... The hPASCs from 14 human gonadotrophic pituitary adenoma clinical samples were cultured and verified via immunohistochemistry. Genetic profiling of hPASCs and the matched tumor cells was performed thr... The hPASCs were successfully isolated and cultured from gonadotrophic pituitary adenoma in vitro, which were identified as positive for generic stem cell markers (Sox2, Oct4, Nestin and CD133) via imm... Genetic profiling of hPASCs may explain the tumorigenesis and invasiveness of gonadotrophic pituitary adenoma. ANXA2 may serve as a potential therapeutic target for the treatment of gonadotrophic pitu...